Imatinib Active Not Recruiting Phase 2 Trials for Fibromatosis Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02495519A Trial of Imatinib for Patients With Aggressive Desmoid Tumor (Aggressive Fibromatosis)